Disease Target Research Group
Builds a personalized therapy-toxicity evaluation platform by integrating human-derived 3D model validation technologies with single-cell omics analysis, enhancing innovative drug development capabilities and research support.
- Develops and institutionalizes certified testing methods for Ricin, the only toxic substance testing method in Korea, to expand external utilization.
Research Infrastructure
- Utilizes Korea’s highest-level single-cell and 3D model standard analysis platforms to study disease pathogenesis and to develop treatment and diagnostic technologies.
- Expands external application of Korea’s only toxic substance (Ricin) testing method and carries out official certification.
Establishes and applies phenotype analysis platforms based on single-cell and 3D model systems.

Promotes certification of Ricin testing and the institutionalization of analytical methods.
